Non-alcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Non-alcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-02-15Clinical Trial Update: Efficacy of a Natural Components Mixture in the Treatment of Non Alcoholic Fatty Liver Disease (NAFLD) [NA]
A completed clinical trial evaluating a natural components mixture for non-alcoholic fatty liver disease has results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-05Clinical Trial Update: Investigation of Synbiotic Treatment in NAFLD [NA]
Clinical trial update on synbiotic treatment for non-alcoholic fatty liver disease has completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: S.P.PRO LIVER POWDER is Used to Improve Liver and Metabolic Indexes in People With Non-alcoholic Fatty Liver Disease [Phase 4]
Clinical trial update for S.P.PRO LIVER POWDER in Phase 4 assessing improvements in liver and metabolic indices in non-alcoholic fatty liver…
-
CLINICAL_TRIALS trial_result · 2020-11-12Clinical Trial Update: Gemcabene for the Treatment of Pediatric NAFLD [Phase 2]
Phase 2 trial of gemcabene for pediatric non-alcoholic fatty liver disease was terminated with posted results.
-
CLINICAL_TRIALS withdrawal · 2020-11-05Clinical Trial Update: Silymarin in NAFLD [Phase 4]
Phase 4 clinical trial of silymarin in non-alcoholic fatty liver disease has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-09-25Clinical Trial Update: Impact of a Specific Micronutrient-probiotic-supplement on Fatty Liver of Patients After Mini-Gastric Bypass Surgery [Phase 3]
Phase 3 trial investigating a micronutrient-probiotic supplement's effect on fatty liver in patients after mini-gastric bypass surgery.
-
CLINICAL_TRIALS trial_result · 2020-09-23Clinical Trial Update: A Study To Assess Pharmacodynamics, Safety And Tolerability Of PF-05221304 And PF-06865571 Co-Administered For 6 Weeks In Adults With Non-Alcoholic Fatty Liver Disease. [Phase 2]
Phase 2 trial assessing pharmacodynamics, safety, and tolerability of PF-05221304 and PF-06865571 co-administered for 6 weeks in adults with…
-
CLINICAL_TRIALS research · 2020-09-14Clinical Trial Update: GSP as an Novel Indicator for Residual Liver Function in Patients With Fatty Liver [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating Galactose Single Point (GSP) as a novel indicator of residual liver function in patients with fatty li…
-
CLINICAL_TRIALS trial_result · 2020-09-02Clinical Trial Update: Treatment of NAFLD With Two Different Diets [Phase 2]
A Phase 2 clinical trial evaluating two different diets for treatment of non-alcoholic fatty liver disease (NAFLD) has completed.
-
CLINICAL_TRIALS trial_result · 2020-08-21Clinical Trial Update: A Study to Evaluate the Safety, Tolerability & Efficacy of MSDC-0602K in Patients With NASH [Phase 2]
Phase 2 study assessing safety, tolerability, and efficacy of MSDC-0602K in patients with non-alcoholic fatty liver disease and non-alcoholi…
-
CLINICAL_TRIALS trial_result · 2020-08-07Clinical Trial Update: Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets on the Patients With Newly Diagnosed Type 2 Diabetes Mellitus Combined With Non-alcoholic Fatty Liver Disease [Phase 4]
Phase 4 trial evaluating the efficacy of pioglitazone hydrochloride and metformin hydrochloride tablets for patients with newly diagnosed ty…
-
CLINICAL_TRIALS trial_result · 2020-07-29Clinical Trial Update: Effectiveness and Tolerability of Phentermine in Patients Under Bariatric Surgery [Phase 4]
Phase 4 trial evaluating the effectiveness and tolerability of phentermine in patients undergoing bariatric surgery.
-
CLINICAL_TRIALS trial_result · 2020-07-09Clinical Trial Update: The Effect of Consecutive Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease (NAFLD) [Phase 4]
A Phase 4 clinical trial update examining the effect of consecutive fecal microbiota transplantation on non-alcoholic fatty liver disease.
-
CLINICAL_TRIALS trial_result · 2020-06-11Clinical Trial Update: Different Doses of BI 1467335 Compared to Placebo in Patients With Clinical Evidence of NASH [Phase 2]
Phase 2 clinical trial comparing different doses of BI 1467335 to placebo in patients with non-alcoholic fatty liver disease (NAFLD) has com…
-
CLINICAL_TRIALS trial_result · 2020-06-04Clinical Trial Update: Efficacy of Phosphatidylcholine in NAFLD [Phase 3]
Phase 3 trial assessing phosphatidylcholine for non-alcoholic fatty liver disease has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-13Clinical Trial Update: 2-Week Study In People With Nonalcoholic Fatty Liver Disease [Phase 1]
A Phase 1 clinical trial update for a two-week study in adults with nonalcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatit…
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: Nicotinamide in Non-Alcoholic Fatty Liver Disease Patients [Phase 2]
Phase 2 trial update for nicotinamide in non-alcoholic fatty liver disease has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-25Clinical Trial Update: Treatment of Non Alcoholic Fatty Liver Disease With n-3 Fatty Acids [Phase 4]
Phase 4 clinical trial assessing treatment of non-alcoholic fatty liver disease with n-3 fatty acids completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-11Clinical Trial Update: ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or Type 2 Diabetes Mellitus (T2DM) and Suspected NAFLD [Phase 2]
Phase 2 trial evaluating cenicriviroc on insulin sensitivity in people with prediabetes or type 2 diabetes and suspected non-alcoholic fatty…
-
CLINICAL_TRIALS research · 2019-08-28Clinical Trial Update: Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 Diabetes [Phase 4]
Clinical trial comparing exenatide with insulin glargine to assess changes in liver fat content in adults with type 2 diabetes and non-alcoh…
-
CLINICAL_TRIALS trial_result · 2019-07-31Clinical Trial Update: Vitamin D in Fatty Liver Disease [Phase 4]
Phase 4 clinical trial update on vitamin D in non-alcoholic fatty liver disease with concomitant vitamin D deficiency; study completed.
-
CLINICAL_TRIALS trial_result · 2019-04-04Clinical Trial Update: 6-week Safety and PD Study in Adults With NAFLD [Phase 2]
Phase 2 safety and pharmacodynamic study in adults with non-alcoholic fatty liver disease completed; results posted in 2019.
-
CLINICAL_TRIALS research · 2019-02-18Clinical Trial Update: Fighting Fatty Liver in India [NA]
A university-sponsored clinical trial addressing non-alcoholic fatty liver disease in India, with the phase and status currently unspecified…
-
CLINICAL_TRIALS research · 2019-02-15Clinical Trial Update: Non-invasive Diagnostic Model of Liver Fibrosis Associated With NAFLD and Prediction of Prognosis
This clinical trial update describes a non-invasive diagnostic model for liver fibrosis associated with non-alcoholic fatty liver disease an…
-
CLINICAL_TRIALS trial_result · 2019-02-08Clinical Trial Update: Runihol in Nonalcoholic Fatty Liver Disease and Metabolic Syndrome [Phase 2]
A Phase 2 trial of Runihol for non-alcoholic fatty liver disease has been terminated.